Business
Eli Lilly Expands Vaccine Portfolio
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases. The move aims to strengthen the company's position in the field and provide a boost to research efforts.
Coverage timeline — 1 article
STAT News
Eli Lilly is acquiring three small vaccine developers, expanding its work in infectious diseases and giving the field a boost.
2026-05-26 11:29 UTC